Japanese encephalitis virus persists in the human reproductive epithelium and porcine reproductive tissues.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
11
05
2022
accepted:
12
07
2022
entrez:
29
7
2022
pubmed:
30
7
2022
medline:
3
8
2022
Statut:
epublish
Résumé
Japanese encephalitis virus (JEV) is the emerging and geographically expanding flavivirus and the major causative agent of encephalitis in humans in Asia. There are risks of JEV introduction into the Americas given a large population of amplifying hosts-pigs and wild boars, and insect vectors-Culex mosquitoes. There are emerging concerns about vector-free ways of flavivirus transmission, for example sexual and transplacental Zika virus transmissions, which may change flavivirus epidemiology and expand the geographical range to territories with no insect vectors. It is unknown whether JEV has tropism in the female lower reproductive tract and the potential for sexual transmission in humans. While clinical outcomes of transplacental JEV infection are described in humans and pigs, cellular targets and tissue tropism in the upper reproductive tract are also unknown. Here, we studied JEV infection phenotypes and host transcriptional responses in human reproductive epithelial cells. We found that JEV caused persistent infection and cytopathology in the vaginal epithelium, endometrial epithelium, and trophoblast. Human vaginal epithelial cells infected with JEV had altered transcriptional responses associated with inflammation and disruption of epithelial barrier function. Also, using pigs-the native amplifying host for JEV, we confirmed JEV tropism in the female lower and upper reproductive tracts. We discovered that JEV persists in the vaginal mucosa for at least 28 days and pigs shed the virus in vaginal secretions. We also found JEV persistence in the endometrium and placenta with transplacental and fetal infections. Altogether, we discovered that JEV targets the vaginal epithelium and has the potential for sexual transmission in humans. We also contributed to a better understanding of JEV pathogenesis during transplacental infection. Further studies are needed to better understand the interactions of JEV with reproductive tissues, how persistent infection affects female reproductive functions, and the risks for non-vector transmission.
Identifiants
pubmed: 35905074
doi: 10.1371/journal.pntd.0010656
pii: PNTD-D-22-00605
pmc: PMC9337681
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010656Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Front Microbiol. 2019 Apr 16;10:811
pubmed: 31057517
Hum Vaccin Immunother. 2014;10(2):263-79
pubmed: 24161909
Biomed Environ Sci. 2018 Mar;31(3):208-214
pubmed: 29673443
J Neurosci. 2007 Oct 3;27(40):10695-702
pubmed: 17913903
PLoS Med. 2017 Jan 3;14(1):e1002203
pubmed: 28045901
Rev Inst Med Trop Sao Paulo. 2019;61:e19
pubmed: 30970110
Sci Rep. 2015 Nov 06;5:16248
pubmed: 26542535
MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14):372-4
pubmed: 27078057
Nat Commun. 2016 Feb 23;7:10832
pubmed: 26902924
J Mol Med (Berl). 2016 Apr;94(4):391-400
pubmed: 26612594
J Anat. 2009 Jul;215(1):3-13
pubmed: 19453302
PLoS Pathog. 2017 Mar 9;13(3):e1006219
pubmed: 28278237
Uirusu. 1977 Jun;27(1):21-6
pubmed: 203101
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):569-72
pubmed: 26061233
Virulence. 2018;9(1):1338-1343
pubmed: 30058440
J Infect Dis. 1980 Jun;141(6):712-5
pubmed: 6248601
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Lancet Infect Dis. 2017 Nov;17(11):1200-1208
pubmed: 28838639
Emerg Infect Dis. 2011 May;17(5):880-2
pubmed: 21529401
Sci Rep. 2018 May 21;8(1):7951
pubmed: 29784969
PLoS Pathog. 2019 Nov 14;15(11):e1008038
pubmed: 31725819
Sci Rep. 2017 Feb 23;7:42941
pubmed: 28230167
MMWR Morb Mortal Wkly Rep. 2016 Jul 22;65(28):716-7
pubmed: 27442327
Front Immunol. 2021 May 17;12:686437
pubmed: 34079560
J Virol. 2018 Nov 27;92(24):
pubmed: 30282716
PLoS Pathog. 2017 Sep 21;13(9):e1006633
pubmed: 28934370
Vet Res. 2016 Feb 24;47:34
pubmed: 26911997
Front Genet. 2019 Nov 13;10:1120
pubmed: 31798629
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
J Prev Med Hyg. 2018 Mar 30;59(1):E99-E107
pubmed: 29938245
EBioMedicine. 2017 Nov;25:73-86
pubmed: 29097124
Transbound Emerg Dis. 2019 Jul;66(4):1558-1574
pubmed: 30900804
Jpn J Exp Med. 1954 Dec;24(6):363-75
pubmed: 13270968
Cell Host Microbe. 2017 Sep 13;22(3):366-376.e3
pubmed: 28910635
Front Cell Infect Microbiol. 2022 Feb 24;12:834888
pubmed: 35281443
Clin Infect Dis. 2017 Jan 1;64(1):107-109
pubmed: 27682065
Bull World Health Organ. 2011 Oct 1;89(10):766-74, 774A-774E
pubmed: 22084515
Fertil Res Pract. 2019 Jan 03;5:1
pubmed: 30619616
JCI Insight. 2018 Nov 2;3(21):
pubmed: 30385728
Viruses. 2021 Sep 14;13(9):
pubmed: 34578408
Euro Surveill. 2014 Apr 03;19(13):
pubmed: 24721538
JAMA. 2017 Jan 3;317(1):59-68
pubmed: 27960197
Trends Endocrinol Metab. 2020 Feb;31(2):165-180
pubmed: 31866217
J Exp Med. 2016 Dec 12;213(13):2913-2929
pubmed: 27852793
PLoS Negl Trop Dis. 2014 Jan 30;8(1):e2533
pubmed: 24498443
Emerg Microbes Infect. 2017 Feb 15;6(2):e6
pubmed: 28196970
Vector Borne Zoonotic Dis. 2018 Sep;18(9):469-474
pubmed: 29742002
Nat Commun. 2017 Feb 21;8:14575
pubmed: 28220786
Front Immunol. 2020 Jan 06;10:2998
pubmed: 31969885
PLoS Pathog. 2017 Jul 26;13(7):e1006537
pubmed: 28746373
Emerg Microbes Infect. 2019;8(1):1098-1107
pubmed: 31340725
Nat Commun. 2019 Jan 17;10(1):280
pubmed: 30655513
Cell Rep. 2016 Dec 20;17(12):3091-3098
pubmed: 28009279
Methods Mol Biol. 2020;2142:181-195
pubmed: 32367368
Immunity. 2015 Jul 21;43(1):15-28
pubmed: 26200010
Cell. 2016 Aug 25;166(5):1247-1256.e4
pubmed: 27565347
Vector Borne Zoonotic Dis. 2015 Nov;15(11):709-11
pubmed: 26565775
J Travel Med. 2018 May 1;25(suppl_1):S3-S9
pubmed: 29718434
Sci Immunol. 2018 Jan 5;3(19):
pubmed: 29305462